Logos Global Management LP has recently announced that it has increased stake in Icosavax Inc (NASDAQ:ICVX) by 27.70%. After grabbing 2.77 million shares, the institutional investor is now in possession of 0.6 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 5.52% having worth around $27.99 million. Moreover, Platinum Investment Management Lt increased its share by 642.0 to have a control over 2.34 million shares. And The Vanguard Group, Inc. raised its holdings to 0.93 million shares by acquiring 1.87 million shares or 3.74% of the stake.
Icosavax Inc (ICVX) concluded trading on 12/21/23 at a closing price of $15.54, with 1.84 million shares of worth about $28.6 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 68.18% during that period and on Thursday the price saw a gain of about 0.84%. Currently the company’s common shares owned by public are about 41.10M shares, out of which, 32.53M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 25 times over the past 12 months. They bought 103,020 shares in 8 of the transactions. In 17 selling transactions, insiders dumped 95,519 shares.
Fidelity Advisor Series I -Growth, T Rowe Price Small Cap Value Fund, and Fidelity Series Small Cap Opportu are the top 3 mutual funds which are holding stakes in Icosavax Inc Fidelity Advisor Series I -Growth is currently holding 1.73 million shares of worth totaling $17.55 million. The company recently came buying 0.0 shares which brought its stake up to 3.46% of the company’s outstanding shares. T Rowe Price Small Cap Value Fund sold -0.13 million shares, after which its hold over company’s outstanding shares shrunk to 2.91%, leaving 1.46 million shares with the mutual fund that have a worth of about $14.75 million. Fidelity Series Small Cap Opportu, after buying 1.21 million shares, have now control over 2.42% of the stake in the company. It holds 0.0 shares of worth $12.26 million.
Icosavax Inc (NASDAQ: ICVX) started trading at $15.64, above $0.23 from concluding price of the previous day. However, the stock later moved at a day high price of 15.70, or with a gain of 0.84%. Stock saw a price change of -0.77% in past 5 days and over the past one month there was a price change of 53.10%. Year-to-date (YTD), ICVX shares are showing a performance of 95.72% which increased to 63.06% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.75 but also hit the highest price of $16.10 during that period. The average intraday trading volume for Icosavax Inc shares is 628.33K. The stock is currently trading 26.66% above its 20-day simple moving average (SMA20), while that difference is up 68.52% for SMA50 and it goes to 88.44% higher than SMA200.
Logos Global Management LP acquired 2.77 million shares of Icosavax Inc having value of about $27.99 million. Data submitted at the U.S SEC by Logos Global Management LP revealed that the firm now holds 0.6 million shares in the company valued at close to $9324000.0, or have control over 27.70% stake in the company. Icosavax Inc (NASDAQ: ICVX) currently have 41.10M outstanding shares and institutions hold larger chunk of about 63.21% of that. Holding of mutual funds in the company is about 25.90% while other institutional holders and individual stake holders have control over 37.33% and 23.14% of the stake respectively.
The stock has a current market capitalization of $778.40M and its 3Y-monthly beta is at 1.20. It has posted earnings per share of -$2.22 in the same period. It has Quick Ratio of 18.06 while making debt-to-equity ratio of 0.03. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ICVX, volatility over the week remained 1.59% while standing at 6.53% over the month.
Analysts are in expectations that Icosavax Inc (ICVX) stock would likely to be making an EPS of -$0.52 in the current quarter, while forecast for next quarter EPS is -$0.54 and it is -$2.11 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.59 which is -$0.46 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.59 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 8.25% while it is estimated to increase by 4.22% in next year.
Analysts at 6 brokerage firms have issued recommendations for the Icosavax Inc (ICVX)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.67. Out of those 6 Wall Street analysts, 4 recommended a “Buy” rating, while 2 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Guggenheim on November 17, 2023 offering a Buy rating for the stock and assigned a target price of $28 to it.
